Evolve HealthCare Partners (“EHP”) is a mid-market private equity firm founded by former international C-level healthcare executives and investors that aims to partner with European healthcare companies with growth and/or strategic repositioning ambitions, both organically or via M&A.
EHP’s approach to value creation is operationally focused and hands-on, thus well-placed to apply differentiated investment strategies focused on improving the growth profile of companies in the healthcare space and being able to generate above average returns to investors in a sector that continues to progress and inspire.
News
April
2021
Evolve HealthCare Partners partners with Cera Care to accelerate continued growth
Barcelona, Spain – Evolve HealthCare Partners, (“Evolve”), the European mid-market specialist investor in healthcare, together with the existing institutional shareholders, have led a capital injection in Cera Care (“Cera” or the “Company”) to support and accelerate its continuous growth.
Evolve has co-invested alongside Schroder Adveq.
May
2020
Healthcare Private Equity: Investing in Post-COVID world
The global Covid-19 crisis will lead to unprecedented change.
Certain healthcare sectors will be re-defined as strategic infrastructure and new trends will emerge that will persist beyond the crisis.
We examine the five key post-Covid-19 trends and the likely investment opportunities that will arise.
DECEMBER
2019
Europe creating more Healthcare specific funds
Novel approaches to value creation in healthcare private equity
Evolve Healthcare Partners featured in the Laing & Buisson Private Equity in Healthcare Market Report 4ed
In addition to traditional levers, a more pragmatic and hands on approach is required to unlock the full potential of healthcare private equity investments
© 2019
All Rights Reserved